PTC-028 (Standard)

Overview

PTC-028 (Standard) is the analytical standard of PTC-028 ( HY-103696 ). This product is intended for research and analytical applications. PTC-028 is an orally bioavailable inhibitor of stem cell factor BMI-1 in ovarian cancer . PTC-028 selectively inhibits cancer cells whereas normal cells remain unaffected. PTC-028 downregulates BMI-1, inducing caspase-mediated apoptosis .

Application

Products | Products > Signaling Pathways > Others | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > BMI1 | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-103696R
• CAS No.: 1782970-28-8
• Molecular Formula: C19H12F5N5
• Molecular Weight: 405.32
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source